AR209319A1 - Procedimiento para la produccion de (omega-1)-oxo-alquil-dialquilxantinas - Google Patents

Procedimiento para la produccion de (omega-1)-oxo-alquil-dialquilxantinas

Info

Publication number
AR209319A1
AR209319A1 AR260112A AR26011275A AR209319A1 AR 209319 A1 AR209319 A1 AR 209319A1 AR 260112 A AR260112 A AR 260112A AR 26011275 A AR26011275 A AR 26011275A AR 209319 A1 AR209319 A1 AR 209319A1
Authority
AR
Argentina
Prior art keywords
dialkylxanthines
omega
oxo
alkyl
procedure
Prior art date
Application number
AR260112A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AR209319A1 publication Critical patent/AR209319A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AR260112A 1973-06-16 1975-08-22 Procedimiento para la produccion de (omega-1)-oxo-alquil-dialquilxantinas AR209319A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (de) 1973-06-16 1973-06-16 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AR209319A1 true AR209319A1 (es) 1977-04-15

Family

ID=5884209

Family Applications (3)

Application Number Title Priority Date Filing Date
AR254209A AR208179A1 (es) 1973-06-16 1974-01-01 Procedimiento para la produccion de (omega-1)-oxoalquildialquilxantinas
AR260113A AR209320A1 (es) 1973-06-16 1975-08-22 Procedimiento para la produccion de (omega-1)-oxoalquildialquilxantinas
AR260112A AR209319A1 (es) 1973-06-16 1975-08-22 Procedimiento para la produccion de (omega-1)-oxo-alquil-dialquilxantinas

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AR254209A AR208179A1 (es) 1973-06-16 1974-01-01 Procedimiento para la produccion de (omega-1)-oxoalquildialquilxantinas
AR260113A AR209320A1 (es) 1973-06-16 1975-08-22 Procedimiento para la produccion de (omega-1)-oxoalquildialquilxantinas

Country Status (17)

Country Link
US (1) US4289776A (es)
JP (1) JPS5233120B2 (es)
AR (3) AR208179A1 (es)
AT (1) AT334388B (es)
BE (1) BE816332A (es)
CH (2) CH612969A5 (es)
DE (1) DE2330742C2 (es)
DK (1) DK145676C (es)
ES (1) ES427171A1 (es)
FI (1) FI58920C (es)
FR (1) FR2233065B1 (es)
GB (1) GB1470220A (es)
IE (1) IE39898B1 (es)
NL (1) NL182806C (es)
NO (1) NO140300C (es)
SE (1) SE423631B (es)
ZA (1) ZA743760B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (es) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
DE3173289D1 (en) * 1980-06-21 1986-02-06 Beecham Wuelfing Gmbh & Co Kg Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IT1197516B (it) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
DK0514789T3 (es) * 1991-05-23 1997-02-17 Hoechst Ag
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
JP2549480B2 (ja) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 排尿障害改善剤
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
WO1995020589A1 (en) * 1994-01-28 1995-08-03 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
JP5292413B2 (ja) 2008-02-29 2013-09-18 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
AU2010289551A1 (en) 2009-09-02 2012-03-01 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2017114843A1 (en) * 2015-12-29 2017-07-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Xanthine derivative inhibitors of bet proteins
CN112724160A (zh) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 一种己酮可可碱杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE1545689C2 (de) 1964-09-05 1982-07-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Methyl-3-carbäthoxy-5,6-dihydropyran
DE1233405B (de) 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
JPS5047992A (es) 1975-04-28
ATA491874A (de) 1976-05-15
AU7014774A (en) 1975-12-18
DK321574A (es) 1975-02-10
FI181974A (es) 1974-12-17
SE423631B (sv) 1982-05-17
FR2233065A1 (es) 1975-01-10
AR209320A1 (es) 1977-04-15
NO140300B (no) 1979-04-30
NL182806B (nl) 1987-12-16
US4289776A (en) 1981-09-15
SE7407913L (es) 1974-12-17
DE2330742A1 (de) 1975-01-09
DK145676B (da) 1983-01-24
ZA743760B (en) 1975-06-25
JPS5233120B2 (es) 1977-08-26
CH612969A5 (es) 1979-08-31
DE2330742C2 (de) 1982-07-29
DK145676C (da) 1983-08-01
CH608807A5 (es) 1979-01-31
GB1470220A (en) 1977-04-14
NL7407890A (es) 1974-12-18
NO140300C (no) 1979-08-08
BE816332A (fr) 1974-12-16
AT334388B (de) 1976-01-10
NO742121L (es) 1975-01-13
IE39898L (en) 1974-12-16
ES427171A1 (es) 1976-07-16
FR2233065B1 (es) 1978-07-21
FI58920C (fi) 1981-05-11
NL182806C (nl) 1988-05-16
FI58920B (fi) 1981-01-30
AR208179A1 (es) 1976-12-09
IE39898B1 (en) 1979-01-31

Similar Documents

Publication Publication Date Title
AR209319A1 (es) Procedimiento para la produccion de (omega-1)-oxo-alquil-dialquilxantinas
AR201880A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol
AR203878A1 (es) Procedimiento para la elaboracion de compuestos del 1-piraziniloxi 2-hidroxi-3-aminopropano
AR204996A1 (es) Procedimiento para la preparacion de 5-metil-7-hidroxi o 7-alcoxi-isoflavonas
AR204928A1 (es) Procedimiento para la preparacion de(alquil-tioalquil)tioureas heterociclicas
MX4588E (es) Procedimiento para la preparacion de i-ariloxi-2-hidroxi-3-alquinilaminopropanos
IT1029594B (it) Procedimento per la produzione di benzochino
AR210725A1 (es) Procedimiento para la preparacion de derivados de dibenzoxepina
AR203188A1 (es) Procedimiento para la preparacion de derivados de tienotriazolodiacepina
AR207022A1 (es) Procedimiento para la preparacion de poli-n-dimetiliminoalano
IT1029578B (it) Procedimento per la produzione pirazoli sostituite
AR207230A1 (es) Procedimiento para la preparacion de d-homoesteroides
AR211918A1 (es) Metodo para la preparacion de n-carbamoil-2-feniletensulfonamida
AR207450A1 (es) Procedimiento para la produccion de derivados de 4-fenilsulfonil-metil-prehidroindan-5-onas
AR206658A1 (es) Procedimiento para la produccion de nuevos diariloxi-imidazolilacetales
AR203196A1 (es) Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima
AR200171A1 (es) Procedimiento para la produccion de nuevas benzoilfenilguanidinas
AR198586A1 (es) Procedimiento para la produccion de 5-nitro-naftoquinona-(1,4)
AR203359A1 (es) Procedimiento para la produccion de nuevas n'-(aminoacilaminofenil)-acetamidinas
IT1005996B (it) Procedimento per la produzione di cumolo
IT1018640B (it) Procedimento per la produzione di n alchilpiperazine
AR200552A1 (es) Procedimiento para la produccion de 1-omega-cianoalquilcarbamoil-2-acilamino-benzimidazoles
AR199824A1 (es) Procedimiento para la produccion de nuevas benzoilfenilisotioureas
AR213076A1 (es) Procedimiento para la produccion de derivados de la glicilglicilanilida sustituida
ES550171A0 (es) Procedimiento para la preparacion de espiramicina microen- capsulada